Australian Genomics has developed a position statement on the use of genomic information in life insurance and related policies.
It includes supporting a nationally-consistent approach to the use of genomic information by the insurance industry, one that ensures those undertaking clinical testing and/or participating in research are not subject to inappropriate discrimination in life insurance and related policies.
“We believe the Australian Government should take a leadership role in regulating the use of genomic information by the insurance industry and implement an interim moratorium on the use of genetic test results,” the statement says.
The position statement was prepared by Dr Andrea Belcher, Tiffany Boughtwood, Merryn Pearce and A/Prof Ainsley Newson on behalf of Australian Genomics. This position statement was reviewed by Australian Genomics’ National Implementation Committee, Community Advisory Group, Independent Advisory Board and approved by the National Steering Committee in November 2018.
